Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD
Authors
Keywords
-
Journal
Clinical Journal of the American Society of Nephrology
Volume 15, Issue 1, Pages 47-60
Publisher
American Society of Nephrology (ASN)
Online
2019-12-13
DOI
10.2215/cjn.07320619
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
- (2019) Archna Bajaj et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States
- (2018) Rajiv Saran et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial
- (2018) Antonio J. Vallejo-Vaz et al. CIRCULATION
- Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease
- (2018) Julio A Lamprea-Montealegre et al. HEART
- The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
- (2018) Pratik B Sandesara et al. ENDOCRINE REVIEWS
- Lipid management in patients with chronic kidney disease
- (2018) Charles J. Ferro et al. Nature Reviews Nephrology
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- The majority of lipoprotein lipase in plasma is bound to remnant lipoproteins: A new definition of remnant lipoproteins
- (2016) Koichi Sato et al. CLINICA CHIMICA ACTA
- Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP)
- (2016) Natalie Staplin et al. Clinical Journal of the American Society of Nephrology
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein
- (2015) Valentina Kon et al. ARCHIVES OF MEDICAL RESEARCH
- The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
- (2015) Frank M. Sacks CURRENT OPINION IN LIPIDOLOGY
- Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial
- (2015) Roberto S. Kalil et al. KIDNEY INTERNATIONAL
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Trends in Lipids and Lipoproteins in US Adults, 1988-2010
- (2012) Margaret D. Carroll et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease
- (2011) Esther M. M. Ooi et al. JOURNAL OF LIPID RESEARCH
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
- (2010) SHARP Collaborative Group AMERICAN HEART JOURNAL
- Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
- (2010) Chunyu Zheng et al. CIRCULATION
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Combination Lipid Therapy in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III
- (2009) Doris T. Chan et al. JOURNAL OF LIPID RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation